PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China: Purpose This study evaluated the efficacy and safety in a real-world population of epithelial ovarian cancer (EOC)…… #oncology https://t.co/N
RT @FrontOncology: New research: PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from…
RT @FrontOncology: New research: PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from…
New research: PARP inhibitor maintenance treatment for newly diagnosed ovarian cancer patients: a real-world study from China: Purpose This study evaluated the efficacy and safety in a real-world population of epithelial ovarian cancer (EOC)… https://t.co